Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey

PURPOSE: Despite the increasing use of adjuvant bone-modifying agents (BMAs) such as zoledronate and clodronate in the treatment of patients with early stage breast cancer (EBC), little is known about real world practice patterns. A physician survey was performed to address this deficit and determin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: McGee, Sharon, Alzahrani, Mashari, Vandermeer, Lisa, Cole, Katherine, Larocque, Gail, Awan, Arif, Hutton, Brian, Pond, Gregory, Saunders, Deanna, Clemons, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2021
Assuntos:
Clinical Trial
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7985746/
https://ncbi.nlm.nih.gov/pubmed/33755864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-021-06147-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados